Related Experiment Video
Updated: Apr 24, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
The case for treating refractory congestive heart failure with ultrafiltration
Bernard Canaud1, Sudhir K Bowry, Ciro Tetta
1Fresenius Medical Care, Bad Homburg, Germany.
Isolated ultrafiltration (UF) offers a promising mechanical diuretic approach for heart failure (HF) patients with cardiorenal syndrome (CRS). This therapy aids fluid removal in diuretic-resistant cases, potentially improving HF outcomes.
Area of Science:
- Cardiology
- Nephrology
- Critical Care Medicine
Background:
- Extracellular fluid retention and congestion are key manifestations of heart failure (HF) and cardiorenal syndrome (CRS).
- Diuretic resistance and severe congestion are primary drivers of HF hospital admissions and readmissions, often leading to poor patient outcomes.
- Current treatments for fluid overload in HF-CRS are frequently limited by diuretic resistance.
Purpose of the Study:
- To outline the rationale for machine-driven isolated ultrafiltration (UF) in managing cardiorenal syndrome (CRS) within heart failure (HF) patients.
- To review the existing clinical evidence supporting the use of isolated UF in HF patients with CRS.
- To summarize future clinical perspectives for enhancing UF therapy in HF to improve patient outcomes.
Main Methods:
- Review of existing literature and clinical evidence on isolated ultrafiltration (UF) in heart failure (HF) and cardiorenal syndrome (CRS).
- Analysis of UF as a 'mechanical diuretic and natriuretic' tool for fluid volume removal.
- Exploration of machine-driven UF protocols and their application in diuretic-resistant HF-CRS.
Main Results:
- Isolated ultrafiltration (UF) demonstrates potential as a safe and effective method for fluid volume removal in HF patients with CRS.
- UF serves as a mechanical alternative to diuretics, particularly beneficial for patients resistant to conventional diuretic therapy.
- Evidence suggests UF can achieve significant fluid and natriuretic effects in congested HF patients.
Conclusions:
- Machine-driven isolated ultrafiltration (UF) presents a viable therapeutic option for heart failure (HF) patients experiencing cardiorenal syndrome (CRS) and fluid overload.
- UF therapy holds promise for improving outcomes in HF patients, especially those with diuretic resistance.
- Further research and expanded clinical application of UF are warranted to optimize its role in managing complex HF cases.
More Related Videos
10:19Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing
Published on: February 13, 2016
12:47Tangential Flow Ultrafiltration: A “Green” Method for the Size Selection and Concentration of Colloidal Silver Nanoparticles
Published on: October 4, 2012
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Heart Failure VI: Adjunct Therapies
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management